Supplement use during an intergroup clinical trial for breast cancer (S0221)

The use of supplements during chemotherapy is controversial, partly due to the potential effect of antioxidants on reduced efficacy of chemotherapy-related cytotoxicity. We examined supplement use among breast cancer patients registered to a clinical trial (SWOG 0221) before diagnosis and during tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zirpoli, Gary R., Brennan, Patrick M., Hong, Chi-Chen, McCann, Susan E., Ciupak, Gregory, Davis, Warren, Unger, Joseph M., Thomas Budd, G., Hershman, Dawn L., Moore, Halle C.F., Stewart, James, Isaacs, Claudine, Hobday, Timothy, Salim, Muhammad, Hortobagyi, Gabriel N., Gralow, Julie R., Albain, Kathy S., Ambrosone, Christine B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552360/
https://www.ncbi.nlm.nih.gov/pubmed/23306462
http://dx.doi.org/10.1007/s10549-012-2400-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552360/
https://www.ncbi.nlm.nih.gov/pubmed/23306462
http://dx.doi.org/10.1007/s10549-012-2400-2

Ejemplares similares